David Hyungki Lee, MD
Physical Medicine and Rehabilitation
Accepting new patients
Sees patients age 18 and up
Penn Physical Medicine and Rehabilitation Plainsboro
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Physical Medicine and Rehabilitation

Dr. Lee is a physiatrist specializing in the functional recovery of cancer patients, as well as rehabilitation for primary and secondary lymphedema. He treats a variety of conditions patients may experience during or after cancer treatment, including musculoskeletal pain or weakness, neuralgias, neuropathy, decreased joint range of motion, radiation fibrosis, and fatigue and endurance-related issues. Dr. Lee is passionate about educating his lymphedema patients on the diagnosis and treatment of the condition. As part of his practice, he offers a number of interventions with and without ultrasound guidance for cancer patients, such as corticosteroid joint injections, botulinum toxin injections, and trigger point injections.

Education and training

  • Medical School: New York Medical College
  • Residency: Metropolitan Hospital Center
  • Residency: JFK Medical Center

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
  • Princeton Medical Center: Has privileges to treat patients in the hospital.
Dr. Lee is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

McLarney, Mitra; Johnson, Taylor; Bajaj, Gurtej; Lee, David; Zheng, Jasmine Cancer Pain and Frailty: A Scoping Review of How Cancer Pain Is Evaluated and Treated in the Frail and Elderly , Rehabilitation Oncology, 41(2): 2023,69-77